The Cost Effectiveness of Elective Surgical Procedures with Longer NHS Waiting Lists: A Targeted Review
Applied Health Economics and Health Policy · 2025
DOI: 10.1007/s40258-025-00975-8 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Applied Health Economics and Health Policy, 2025. Verfasst von Laura A Trigg und 5 weiteren Autor:innen. Beteiligte Einrichtung: Peninsula Technology Assessment Group (PenTAG), Department of Public Health and Sports Science, Medical School, University of Exeter, Exeter, UK. Hauptthemen laut MEDLINE: Elective Surgical Procedures, Cost-Benefit Analysis, Waiting Lists, State Medicine. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 53 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: NHS England.
Abstract (Originalsprache)
OBJECTIVES: Our aim was to review the evidence for the cost effectiveness of elective surgeries with long waiting lists within the NHS in England. This is to inform understanding of national spending priorities in the context of significant demand for elective surgeries and to inform the debate on appropriate cost-effectiveness thresholds across healthcare decision making. METHODS: We conducted a targeted literature review to identify published cost-effectiveness analyses for nine elective procedures with long waiting lists in the NHS, selected based on previous reviews. These were percutaneous coronary intervention (PCI), coronary artery bypass graft surgery (CABG), hysterectomy, cholecystectomy, knee replacement, groin hernia repair, hip replacement, prostatectomy, and cataract surgery. We made comparisons adjusted for currency and price year (2024). RESULTS: We identified 21 evaluations; in these, the cost effectiveness of surgeries was compared with no surgery (n = 9), medical management (n = 5), and between early and delayed surgery (n = 10). The evaluations reported that almost all procedures would be considered cost effective yielding incremental cost-effectiveness ratios (ICERs) below £20,000 per quality-adjusted life-year gained. Cholecystectomy, prostatectomy, hip and knee replacement surgeries were associated with ICERs of between £5,000 and £10,000. CONCLUSIONS: These findings offer insights for policymakers on optimising finite healthcare resources, particularly post-COVID-19, with surgical waiting lists a priority for the NHS. Prioritising these elective procedures is likely to be a highly cost-effective use of NHS resources. Allocation of investment to areas that are more cost effective than others is likely to increase the efficiency of the NHS, resulting in a net health gain compared with the reimbursement of less cost-effective interventions.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Autor:innen und Institutionen
- Peninsula Technology Assessment Group (PenTAG), Department of Public Health and Sports Science, Medical School, University of Exeter, Exeter, UK.
- Peninsula Technology Assessment Group (PenTAG), Department of Public Health and Sports Science, Medical School, University of Exeter, Exeter, UK. c.farmer@exeter.ac.uk.
ORCID-Profile: Caroline Farmer
Förderung
- NHS England
Zitieren
APA
Trigg, L. A., Farmer, C., Muthukumar, M., Wilson, E. C. F., Lovell, A., & Lee, D. (2025). The Cost Effectiveness of Elective Surgical Procedures with Longer NHS Waiting Lists: A Targeted Review. Applied Health Economics and Health Policy. https://doi.org/10.1007/s40258-025-00975-8
Vancouver
Trigg LA, Farmer C, Muthukumar M, Wilson ECF, Lovell A, Lee D. The Cost Effectiveness of Elective Surgical Procedures with Longer NHS Waiting Lists: A Targeted Review. Applied Health Economics and Health Policy. 2025. doi:10.1007/s40258-025-00975-8
BibTeX
@article{Trigg2025,
author = {Trigg, Laura A and Farmer, Caroline and Muthukumar, Madhusubramanian and Wilson, Edward C F and Lovell, Alan and Lee, Dawn},
title = {The Cost Effectiveness of Elective Surgical Procedures with Longer NHS Waiting Lists: A Targeted Review},
journal = {Applied Health Economics and Health Policy},
year = {2025},
doi = {10.1007/s40258-025-00975-8}
}
EUVIMED